Explore UAB

Colleges & Schools

Alabama Child Health Improvement Alliance Heersink School of Medicine

4 - Disparities in Vaccine Preventable Diseases: The HPV Example

Tamera Coyne-Beasley, MD, MPH, Professor, Derroll M. Dawkins, M.D. Endowed Chair in Adolescent Medicine, Vice Chair for Community Engagement, University of Alabama at Birmingham. 

Required for MOC- Complete by April 21, 2022, for QI Collaborative 

Speaker Disclosure

Tamera Coyne-Beasley, MD, MPH

  • Does not intend to discuss any commercial products or services.

  • Does not intend to discuss non-FDA approved uses of products/providers of services

  • Does not have a relevant financial relationship with any commercial interests.

  • I have served on external scientific advisory boards for Pfizer, Moderna, Dynavax and Sanofi Pasteur in the past 12 months.
  • Any information presented will be consistent with recommendations of the ACIP and professional organizations. 

Introduction

This final module examines disparities in vaccine preventable diseases using HPV and COVID-19 as examples. The historical context of the effectiveness of vaccines in eradicating disease and reducing health disparities is also presented.  Learners will be asked to identify disparities in vaccination in their offices and how they may improve equity in the allocation, acceptance and uptake of adolescent vaccinations. 

Learning Objectives

Upon completion of this internet enduring material activity, the participant should be able to:

  • Recognize the importance of vaccination
  • Discuss HPV infection and disease
  • Recognize HPV health disparities
  • Identify areas of improvment for vaccine equity in your practice 

Please review the information below and follow the instructions to view the training, complete the online evaluation form, and successfully pass the online post-test, which will automatically submit for CME credit(s).

Commercial Support

This activity does not receive funding from any ineligible company. An ineligible company is any entity producing, marketing, selling, re-selling or distributing healthcare goods or services consumed by, or used on, patients.

Disclaimer Statement

This Internet Enduring Material activity does not necessarily reflect the views, opinions, policies or procedures of the Alabama Chapter-American Academy of Pediatrics, Children’s of Alabama, or its staff or representatives.  Alabama Child Health Improvement Alliance cannot and does not assume any responsibility for the use, misuse or misapplication of any information.

Designation Statement

Children of Alabama designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of the State of Alabama through the joint providership of Children's of Alabama and the Alabama Child Health Improvement Alliance.  Children's of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians. 

Enduring Materials Information

Formats Available: Streaming*
On-Demand Release Date: 11/16/2021

On-Demand Expiration Date: 11/16/2022

Please note that effective July 1, 2011, enduring materials are required to provide an assessment of the learner that measures achievement of the educational purpose and/or objectives of the activity.  Upon completion of this activity, you will be directed to the post-test.  To receive your CME certificate, you must score a minimum of 75% on the test.

Instructions

All three steps are required:

1. Video Training

” Teen Vaccine Disparities” Tamera Coyne-Beasley, MD, MPH, Professor, Derroll M. Dawkins, M.D. Endowed Chair in Adolescent Medicine, Vice Chair for Community Engagement, University of Alabama at Birmingham (Video Time: 25 min)

 Click HERE to access the video.  It is recommended that you access the PowerPoint presentation handout HERE to review as you watch the video.  You will be instructed to return here to access the post-test and CME activity evaluation.

2. Post-Test

For non-physician:To take test non-physician posttest. You must click through and complete entire test (75% pass rate) for your test results to be submitted for CME credit AND certification.  On the last screen you will see your test score and if passing you will be sent a CME certificate from Linda Champion. 

For MD: To take test, choose physician post-test.You must click through and complete entire test (75% pass rate) for your test results to be submitted for MOC Part 2 credit AND certification.

Credit Assignment Criteria: Upon completion of the activity and successfully passing the post test, you will be sent a MOC Part 2 Claim form to complete and return back to Linda Champion at lchampion@alaap.org. On this form you will be required to enter your American Board of Pediatrics (ABP) Diplomate number*) and date of birth (MM/DD). Your ABP Diplomate number can be found in your ABP online profile. If you are unable to locate this number, you may look it up by clicking here or please contact the American Board of Pediatrics [Telephone: (919) 929-0461, Business Hours: (8:30 am – 5:00 pm ET Monday – Friday), E-mail: abpeds@abpeds.org].

*Please note that your American Academy of Pediatrics member ID number is not accepted for MOC Part 2 credit reporting.

Your credit will be entered into the ACCME’s Program and Activity Reporting System (PARS), this system will transfer your credit into your ABP profile. 

Within 30 days after you finish a MOC Part 2 activity that is approved for ABP’s MOC Part 2 credit, your Part 2 points will appear automatically in your ABP Portfolio, MOC Part 2 credit. CME providers are responsible for reporting your completion to the ABP within 30 days. You do not have to send separate documentation to the ABP.

3. Evaluation

Click HERE to take/submit CME activity evaluation.

Vaccine Disparities Bibliography

Includes anal and rectal squamous cell carcinomas: Sources: Senikomago et al. MMWR 2019 and Saraiya et al. J Natl Cancer Inst. 201 https://www.cdc.gov/mmwr/volumes/68/wr/mm6833a3.htm 

Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M, Centers for Disease Control and Prevention (CDC). Human papillomavirus–associated cancers—United States, 2008–2012. MMWR 2016;65(26):661–666.   https://www.cdc.gov/mmwr/volumes/65/wr/mm6526a1.htm

Coyne-Beasley T, Hill SV, Zimet G. COVID-19 Vaccination of Adolescents and Young Adults of Color: Viewing Acceptance and Uptake With a Health Equity Lens. Adolesc Health. 2021 May;68(5):844-846.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016552/